Immunogenicity and reactogenicity of COVID-19 Pfizer-BioNTech (Bnt162b2) mRNA vaccination in immunocompromised adolescents and young adults: a systematic review and meta-analyses-Reference-Cited by-同舟云学术

Immunogenicity and reactogenicity of COVID-19 Pfizer-BioNTech (Bnt162b2) mRNA vaccination in immunocompromised adolescents and young adults: a systematic review and meta-analyses

Published:2023-04-20 Issue:1 Volume:22 Page:378-392
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Katoto Patrick DMC¹²³,Kakubu Mireille AM⁴,Tamuzi Jacques L.²,Brand Amanda S.²,Ayuk Adaeze⁵,Byamungu Liliane N.⁶,Wiysonge Charles S.²⁷⁸^ORCID,Gray Glenda¹

Affiliation:

1. Office of the President and CEO, South African Medical Research Council, Cape Town, South Africa

2. Centre for Evidence-based Health Care, Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa

3. Centre for Tropical Diseases and Global Health, Department of Medicine, Catholic University of Bukavu, Bukavu, DR Congo

4. Ministry of Health and Social Services of Namibia, Windhoek, Namibia

5. Department of Paediatrics and Child Health, University of Nigeria Teaching Hospital, Enugu, Nigeria

6. Department of Paediatric, Faculty of Medicine and Health Sciences, University of KwaZulu-Natal, Durban, South Africa

7. Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa

8. HIV and other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2023.2204154

Reference32 articles.

1. WHO Coronavirus (COVID-19) Dashboard. [cited 2022 Nov 14]; Available from: https://covid19.who.int.

2. COVID-19 disease in children and adolescents: scientific brief 29 Sep 2021. [cited 2022 Nov 14]; Available from: https://www.who.int/publications-detail-redirect/WHO-2019-nCoV-Sci_Brief-Children_and_adolescents-2021.1.

3. Humoral response and safety of BNT162b2 mRNA vaccine in children with rheumatic diseases

4. Safety and immunogenicity of BNT162b2 mRNA COVID-19 vaccine in adolescents with rheumatic diseases treated with immunomodulatory medications

5. Impact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical care

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 antibodies in adolescents living with perinatally acquired HIV;Southern African Journal of Infectious Diseases;2024-03-26